Palatin Technologies is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Carl Spana, with a market cap of $32.5M.
Common questions about Palatin Technologies
Palatin Technologies is scheduled to report earnings for Q3 2026 on May 9, 2026. Analysts estimate revenue of $1.3M.
Palatin Technologies has approximately 33 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.